I am a
Home I AM A Search Login

Papers of the Week


Papers: 23 Apr 2022 - 29 Apr 2022

PAIN TYPE:
Migraine/Headache


2022 Apr 25


Headache

Evaluating the clinical utility of the patient-identified most bothersome symptom measure from PROMISE-2 for research in migraine prevention.

Authors

Lipton RB, Goadsby PJ, Dodick DW, McGinley JS, Houts CR, Wirth RJ, Kymes S, Ettrup A, Østerberg O, Cady R, Ashina M, Buse DC
Headache. 2022 Apr 25.
PMID: 35466430.

Abstract

To assess the utility of the novel patient-identified (PI) most bothersome symptom (MBS) measure from PROMISE-2, a phase 3 trial of eptinezumab for the preventive treatment of chronic migraine.